Cargando…
Managing rheumatoid arthritis during COVID-19
The outbreak of coronavirus in the world has led to an uncertainty about treatment of patients with autoimmune disorders because of their weakened immune system coupled with immunosuppressive agents they take which predisposes them to a host of infections. Data on COVID-19 patients with underlying r...
Autores principales: | Roongta, Rashmi, Ghosh, Alakendu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474575/ https://www.ncbi.nlm.nih.gov/pubmed/32892311 http://dx.doi.org/10.1007/s10067-020-05358-z |
Ejemplares similares
-
Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature
por: Pal, Atanu, et al.
Publicado: (2023) -
Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature
por: Pal, Atanu, et al.
Publicado: (2023) -
Two flares of Still’s disease after two doses of the ChAdOx1 vaccine
por: Roongta, Rashmi, et al.
Publicado: (2022) -
Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study
por: Dubey, Lily, et al.
Publicado: (2016) -
Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration
por: Guin, Aharna, et al.
Publicado: (2019)